Literature DB >> 11069066

Expression of Ly49A on T cells alters the threshold for T cell responses.

L Oberg1, M Eriksson, L Fahlén, C L Sentman.   

Abstract

In this study we investigated the balance between activating and inhibitory signals during T cell activation. We have used transgenic mice in which CD8+ T cells expressed an inhibitory receptor, Ly49A, and a specific activating alphabeta TCR. This TCR recognizes an lymphocytic choriomeningitis virus peptide in combination with H-2Db. We observed a quantitative influence on cellular responses that depended upon the activating signals received through the TCR and the inhibitory signals received through Ly49A. By varying the peptide concentration given to stimulating cells or target cells, we could adjust the amount of ligand available to trigger the TCR. At low doses of peptide, Ly49A-expressing T cells were unresponsive on target cells that expressed H-2Dd, but responded against target cells without H-2Dd. However, this inhibition could be overcome by increasing the peptide concentration or by addition of anti-Ly49A F(ab')2 fragments. Thus, rather than behaving as simple "off" switches, our data indicate that Ly49 receptors modulate T cell signaling so that higher amounts of activating signals are required for effector-cell responses.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11069066     DOI: 10.1002/1521-4141(200010)30:10<2849::AID-IMMU2849>3.0.CO;2-6

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  7 in total

1.  Receptor/ligand avidity determines the capacity of Ly49 inhibitory receptors to interfere with T-cell receptor-mediated activation.

Authors:  Anick Chalifour; Joanne Roger; Suzanne Lemieux; Pascale Duplay
Journal:  Immunology       Date:  2003-05       Impact factor: 7.397

2.  MHC-dependent and -independent modulation of endogenous Ly49 receptors on NK1.1+ T lymphocytes directed by T-cell receptor type.

Authors:  Markus Sköld; Martin Stenström; Stephane Sidobre; Petter Höglund; Mitchell Kronenberg; Susanna Cardell
Journal:  Immunology       Date:  2003-11       Impact factor: 7.397

3.  Primary infection of C57BL/6 mice with Plasmodium yoelii induces a heterogeneous response of NKT cells.

Authors:  Valérie Soulard; Jacques Roland; Christèle Sellier; Anne Charlotte Gruner; Maria Leite-de-Moraes; Jean-François Franetich; Laurent Rénia; Pierre-André Cazenave; Sylviane Pied
Journal:  Infect Immun       Date:  2007-02-16       Impact factor: 3.441

Review 4.  Cytotoxic lymphocytes and atherosclerosis: significance, mechanisms and therapeutic challenges.

Authors:  Tin Kyaw; Karlheinz Peter; Yi Li; Peter Tipping; Ban-Hock Toh; Alex Bobik
Journal:  Br J Pharmacol       Date:  2017-06-13       Impact factor: 8.739

5.  Ligand-dependent inhibition of CD1d-restricted NKT cell development in mice transgenic for the activating receptor Ly49D.

Authors:  Roger B Voyle; Friedrich Beermann; Rosemary K Lees; Jens Schümann; Jacques Zimmer; Werner Held; H Robson MacDonald
Journal:  J Exp Med       Date:  2003-04-07       Impact factor: 14.307

6.  Transgenic expression of the activating natural killer receptor Ly49H confers resistance to cytomegalovirus in genetically susceptible mice.

Authors:  Seung-Hwan Lee; Ahmed Zafer; Yves de Repentigny; Rashmi Kothary; Michel L Tremblay; Philippe Gros; Pascale Duplay; John R Webb; Silvia M Vidal
Journal:  J Exp Med       Date:  2003-02-17       Impact factor: 14.307

7.  Increased CD160 expression on circulating natural killer cells in atherogenesis.

Authors:  Jin Zuo; Zhaoliang Shan; Lin Zhou; Jian Yu; Xiaopeng Liu; Yuan Gao
Journal:  J Transl Med       Date:  2015-06-13       Impact factor: 5.531

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.